I believe these assessments are made on a general rather than an individual basis. It's not a question of whether treatment should be approved for an individual

I believe these assessments are made on a general rather than an individual basis. It's not a question of whether treatment should be approved for an individual patient ("death panels") but whether a treatment is sufficiently effective for its cost to be made available.